AB 2522: Sales and Use Tax Law: exemption: over-the-counter medication.
This bill would exempt over-the-counter medication from state sales and use tax until January 1, 2032. The exemption would apply to the sale and use of medication in California, but not to local sales and use taxes or transactions and use taxes. Additionally, the exemption would not affect state sales and use tax rates dedicated for local government funding. The bill would take effect immediately as a tax levy, and it would require findings and performance indicators to be included in future legislation authorizing the tax expenditure.
| Apr. 27, 2026 | In committee: Set, second hearing. Held under submission. |
| Apr. 06, 2026 | In committee: Set, first hearing. Referred to REV. & TAX. suspense file. |
| Mar. 09, 2026 | Referred to Com. on REV. & TAX. |
| Feb. 21, 2026 | From printer. May be heard in committee March 23. |
| Feb. 20, 2026 | Read first time. To print. |